Better treatment options. Better outcomes.
Better treatment options.
Better outcomes.

Significant patient population and market opportunity for minimally invasive treatment of cerebral aneurysms

Approximately 1 in 50 people in the U.S. have an unruptured brain aneurysm (roughly 6 million people)1
U.S. neurovascular market is expected to grow to over $600 million by 2020: with CAGR of 4.7%2
About 30,000 people in the U.S. experience a brain aneurysm rupture each year (8-10 per 10,000 people)1
Global neurovascular devices market valued at USD $1.62 billion in 2015 and estimated to reach USD $2.92 billion by 2024: with CAGR of 6.5%
This Growth can be linked to:

An increasing patient base with neurovascular diseases such as brain aneurysm and strokes

Improving healthcare infrastructure across the globe

Increasing demand for minimally invasive surgeries